Upon the discovery that SF2312 has anticancer activity in ENO1-deleted glioblastoma via ENO2 inhibition5, we became interested in examining this natural product to determine whether or not its antibiotic effects were mediated through the bacterial enolase, and, if so, what interactions were essential to the inhibitory process. Here, ENO1 is linked to glioblastoma.